MPA inhibits idarubicin activity on Cu-Zn SOD and catalase.
Crispino
L
L
Dipartimento di Strutture, Funzioni e Tecnologie Biologiche, Università di Napoli "Federico II", Via Veterinaria, 1-80137 Napoli, Italy.
Ciarcia
R
R
Montagnaro
S
S
Pagnini
R
R
Pacelli
F
F
Florio
S
S
D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology; D002374:Catalase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015255:Idarubicin / Q000494:pharmacology*; D007700:Kinetics; D017258:Medroxyprogesterone Acetate / Q000494:pharmacology*; D051381:Rats; D013482:Superoxide Dismutase / Q000037:antagonists & inhibitors / Q000378:metabolism*
D018931:Antineoplastic Agents, Hormonal; D017258:Medroxyprogesterone Acetate; D002374:Catalase; D013482:Superoxide Dismutase; D015255:Idarubicin